Related Experiment Video

Updated: May 29, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

The impact of illicit drug use on spontaneous hepatitis C clearance: experience from a large cohort population study

Hossein Poustchi1, Saeed Esmaili, Ashraf Mohamadkhani

  • 1Digestive Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Tehran, Iran.

Plos One
|September 3, 2011
PubMed

Insights

Illicit drug use is linked to chronic Hepatitis C Virus infection, not spontaneous clearance. This finding emerged from a large Iranian study examining factors associated with Hepatitis C Virus (HCV) clearance.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C Virus (HCV) infection often leads to chronic disease, but spontaneous clearance occurs in some individuals.
  • Understanding factors influencing spontaneous clearance is crucial for managing HCV infection.
  • This study investigates demographic correlates of spontaneous HCV clearance in a large Iranian cohort.

Purpose of the Study:

  • To identify demographic factors associated with spontaneous clearance of Hepatitis C Virus infection.
  • To differentiate between chronic HCV infection and spontaneous clearance in a population-based study.
  • To analyze the relationship between illicit drug use and HCV clearance outcomes.

Main Methods:

  • Utilized stored serum samples from the Golestan Cohort Study (n=49,338).
  • Screened samples for anti-HCV antibodies using ELISA, followed by RIBA and PCR for confirmation.
  • Defined spontaneous clearance as positive RIBA with negative PCR, re-tested after 6 months if necessary.

Main Results:

  • Prevalence of chronic HCV infection was 0.31%.
  • The spontaneous clearance rate among those infected with HCV was 38%.
  • Illicit drug use (both injecting and non-injecting) was significantly associated with chronic HCV infection versus spontaneous clearance.

Conclusions:

  • Illicit drug use is the sole significant correlate differentiating chronic HCV infection from spontaneous clearance.
  • Potential mechanisms for this association include repeated exposure to the Hepatitis C Virus antigen.
  • Findings highlight the importance of considering drug use patterns in the context of HCV infection outcomes.
Abstract

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance01:09

Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance

Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...